Enable JavaScript to visit this website.

About Viatris

Frequently Asked Questions

Q: What is Viatris?
A: Viatris is a new company that is the combination of Mylan and Upjohn, a legacy division of Pfizer.
Q: Which products from Upjohn, a legacy division of Pfizer, will be included in the transition to Viatris?
A: The following products will be included in the transition to Viatris:
  • CADUET®(amlodipine besylate/atorvastatin calcium) tablets
  • CARDURA®(doxazosin mesylate) tablets
  • CARDURA® XL (doxazosin mesylate extended
  • CELEBREX®(celecoxib) capsules
  • DETROL®(tolterodine tartrate) tablets
  • DETROL® LA(tolterodine tartrate) extended-release capsules
  • DILANTIN®(extended phenytoin sodium) capsules
  • EFFEXOR XR®(venlafaxine HCl) extended-release capsules
  • GEODON®(ziprasidone HCl)
  • INSPRA®(eplerenone) tablets
  • LIPITOR®(atorvastatin calcium) tablets
  • LYRICA®(pregabalin) Capsules CV
  • LYRICA® CR(pregabalin) extended-release tablets
  • NEURONTIN®(gabapentin)
  • NITROSTAT®(nitroglycerin) sublingual tablet
  • NORVASC®(amlodipine besylate) tablets
  • RELPAX®(eletriptan hydrobromide) tablets
  • REVATIO®(sildenafil) oral suspension
  • REVATIO®(sildenafil) tablets
  • SERMION®(nicergoline) tablets
  • VIAGRA®(sildenafil citrate) tablets
  • XALATAN®(latanoprost ophthalmic solution) 0.005%
  • XANAX® CIV (alprazolam) tablets)
  • ZOLOFT®(sertraline hydrochloride)
Q: How long will Pfizer manage the Patient Assistance Program for legacy Upjohn products?
A: Pfizer will continue to manage the Patient Assistance Program for certain Upjohn products for a period of 12 months from November 16th, 2020
Q: How will this transition impact patient access to medicines?
A: There will be no impact to patients eligible for, or currently participating in, the Pfizer Patient Assistance Program.
Q: Will there be any impact to my current enrollment for these medicines?
A: There will be no impact to a patient’s current enrollment in the Pfizer Patient Assistance Program for these medications.
Q: I receive other Pfizer medicines, will there be changes there too?
A: There will be no changes to how patients access their other Pfizer medicines.
Q: Where can I go for more information about Viatris?
A: For more information about Viatris, please visit their website at www.Viatris.com or call 1-724-514-1800.